A Brief Overview of the Diagnosis and Treatment of Cobalamin (B12) Deficiency

Wolffenbuttel, Bruce H.R., McCaddon, Andrew and Green, Ralph (2024) A Brief Overview of the Diagnosis and Treatment of Cobalamin (B12) Deficiency. Food and Nutrition Bulletin, 45 (1). pp. 40-49. ISSN 1564-8265

Text WURO_wolffenbuttel-et-al-2024-a-brief-overview.pdf - Published Version Available under License Creative Commons Attribution. Download (690kB)

Abstract

Abstract Background: An increasing number of adult individuals are at risk of vitamin B12 deficiency, either from reduced nutritional intake or impaired gastrointestinal B12 absorption. Objective: This study aims to review the current best practices for the diagnosis and treatment of individuals with vitamin B12 deficiency. Methods: A narrative literature review of the diagnosis and treatment of vitamin B12 deficiency. Results: Prevention and early treatment of B12 deficiency is essential to avoid irreversible neurological consequences. Diagnosis is often difficult due to diverse symptoms, marked differences in diagnostic assays’ performance and the unreliability of second-line biomarkers, including holo-transcobalamin, methylmalonic acid and total homocysteine. Reduced dietary intake of B12 requires oral supplementation. In B12 malabsorption, oral supplementation is likely insufficient, and parenteral (i.e. intramuscular) supplementation is preferred. There is no consensus on the optimal long-term management of B12 deficiency with intramuscular therapy. According to the British National Formulary guidelines, many individuals with B12 deficiency due to malabsorption can be managed with 1000 mg intramuscular hydroxocobalamin once every two months after the initial loading. Long-term B12 supplementation is effective and safe, but responses to treatment may vary considerably. Clinical and patient experience strongly suggests that up to 50% of individuals require individualized injection regimens with more frequent administration, ranging from daily or twice weekly to every 2-4 weeks, to remain symptom-free and maintain a normal quality of life. ‘Titration’ of injection frequency based on measuring biomarkers such as serum B12 or MMA should not be practiced. There is currently no evidence to support that oral/sublingual supplementation can safely and effectively replace injections. Conclusions: This study highlights the interindividual differences in symptomatology and treatment of people with B12 deficiency. Treatment follows an individualized approach, based on the cause of the deficiency, and tailored to help someone to become and remain symptom-free.

Item Type:	Article
Keywords:	diagnosis, education, public health, supplementation, vitamin B12.
Divisions:	Applied Science, Computing and Engineering
Depositing User:	Hayley Dennis
Date Deposited:	23 Oct 2024 11:53
Last Modified:	23 Oct 2024 11:53
URI:	https://wrexham.repository.guildhe.ac.uk/id/eprint/18223

Actions (login required)

Edit Item